Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.

MLA

Melmed, Gil Y., et al. “Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 14, no. 9, Sept. 2016, pp. 1302–09. EBSCOhost, https://doi.org/10.1016/j.cgh.2016.05.010.

APA

Melmed, G. Y., Irving, P. M., Jones, J., Kaplan, G. G., Kozuch, P. L., Velayos, F. S., Baidoo, L., Sparrow, M. P., Bressler, B., Cheifetz, A. S., Devlin, S. M., Raffals, L. E., Vande Casteele, N., Mould, D. R., Colombel, J.-F., Dubinsky, M., Sandborn, W. J., & Siegel, C. A. (2016). Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 14(9), 1302–1309. https://doi.org/10.1016/j.cgh.2016.05.010

Chicago

Melmed, Gil Y, Peter M Irving, Jennifer Jones, Gilaad G Kaplan, Patricia L Kozuch, Fernando S Velayos, Leonard Baidoo, et al. 2016. “Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 14 (9): 1302–9. doi:10.1016/j.cgh.2016.05.010.